Related Experiment Video

Updated: May 5, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

1.4K

Phospholipase D-mediated autophagic regulation is a potential target for cancer therapy

Y H Jang1, K Y Choi2, D S Min3

  • 1Department of Molecular Biology, College of Natural Science, Pusan National University, Busan 609-735, Korea.

Cell Death and Differentiation
|December 10, 2013
PubMed

Insights

Phospholipase D (PLD) regulates autophagy, a key process in cellular health and disease. Inhibiting PLD enhances autophagy and cancer regression, suggesting a new therapeutic strategy for cancer treatment.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Autophagy is a vital cellular degradation process crucial for maintaining homeostasis.
  • Dysfunctional autophagy is implicated in various diseases, notably cancer.
  • Phospholipase D (PLD) has emerged as a potential regulator in cellular pathways.

Purpose of the Study:

  • To elucidate the novel role of Phospholipase D (PLD) in regulating autophagy.
  • To investigate the molecular mechanisms by which PLD influences autophagic flux.
  • To explore the therapeutic potential of PLD inhibition in cancer treatment by modulating autophagy.

Main Methods:

  • Investigated the effect of PLD inhibition on autophagic flux using key autophagy-related genes (ATG1/ULK1, ATG5, ATG7).
  • Analyzed the modulation of ULK1 phosphorylation by mTOR and AMPK pathways.
  • Examined the interaction between Beclin 1 and vacuolar-sorting protein 34 (Vps34).
  • Assessed the impact of PLD inhibition on cancer regression in vitro and in vivo.

Main Results:

  • PLD inhibition was found to enhance autophagic flux through essential autophagy gene products.
  • PLD was shown to suppress autophagy by modulating ULK1 phosphorylation via AMPK-mTOR signaling.
  • PLD inhibition disrupted the Beclin 1-Vps34 interaction, a critical step in autophagosome formation.
  • Combined inhibition of PLD and autophagy significantly promoted cancer regression in preclinical models.

Conclusions:

  • Phospholipase D (PLD) plays a novel and significant role in regulating the core molecular machinery of autophagy.
  • PLD inhibition enhances autophagy and potentiates anticancer effects, offering a promising therapeutic avenue.
  • Targeting PLD represents a potential strategy to improve the efficacy of autophagy-based cancer therapies.

More Related Videos

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.5K
Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence08:07

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

Published on: April 28, 2023

2.4K

Related Concept Videos

Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.6K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K